New large study supports longer-term dual anti-platelet (anti-clotting) therapy (DAPT) after a heart stent insertion at least when cardiovascular outcomes are the end-point. But more bleeding may reduce any benefits.
A large study from Japan shows no significant protective effect of low-dose aspirin against cardiovascular mortality among people with risk factors (but no prior CVD history). Now what should doctors advise?
A new advisory from a Federal panel finds strong evidence that low-dose aspirin reduces the risk of preeclampsia in women at risk of this worrisome pregnancy-related condition. Of course, this recommendation should be individualized for patients.
A new study shows a significant benefit in prevention of recurrent venous clots among aspirin users. If confirmed, this would be a major additional benefit for the wonder drug: aspirin!
Dr. J Cuzick from the Queen Mary University of London and international colleagues from several institutions performed a review of studies linking the use of aspirin to decreased risk of several types of cancer and of heart attacks and stroke.
A pancreatic cancer diagnosis most frequently indicates poor prognosis it has among the worst 5-year survival rate of all cancers which
In a small study presented at the AHA meetings, Dutch researchers tested the comparative effect on platelet stickiness of bedtime aspirin vs. morning aspirin. The bedtime dose had a more potent effect, with implications for reducing the toll of morning heart attacks, perhaps.
NBC s headline An aspirin every other day cuts colon cancer risk for women may be catchy,